Comparison of the therapeutic effects of 15 mg and 30 mg initial daily prednisolone doses in patients with subacute thyroiditis: a multicenter, randomized, open-label, parallel-controlled trial

References

• Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6(1):1. doi: 10.1186/1743-422X-6-5.
   PubMedGoogle Scholar
• Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American thyroid association and American association of clinical endocrinologists. Thyroid. 2011;21(6):593–11. doi: 10.1089/thy.2010.0417.
   PubMed Web of Science ®Google Scholar
• Fatourechi V, Aniszewski JP, Fatourechi GZ, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab. 2003;88(5):2100–2105. doi: 10.1210/jc.2002-021799.
   PubMed Web of Science ®Google Scholar
• Ross DS, Burch HB, Cooper DS, et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–1421. doi: 10.1089/thy.2016.0229.
   PubMed Web of Science ®Google Scholar
• Endocrinology CSo. Thyroiditis: a guide to diagnosis and treatment of thyroid diseases in China. Chin J Int Med. 2008;47:784–788.
   Google Scholar
• Ray I, D’Souza B, Sarker P, et al. Management of subacute thyroiditis – a systematic review of current treatment protocols. Int J Gen Med. 2022;15:6425–6439. doi: 10.2147/ijgm.S366784.
   PubMed Web of Science ®Google Scholar
• Vagenakis AG, Abreau CM, Braverman LE. Prevention of recurrence in acute thyoiditis following corticosteroid withdrawal. J Clin Endocrinol Metab. 1970;31(6):705–708. doi: 10.1210/jcem-31-6-705.
   PubMed Web of Science ®Google Scholar
• Yamada T, Sato A, Aizawa T. Dissociation between serum interleukin-6 rise and other parameters of disease activity in subacute thyroiditis during treatment with corticosteroid. J Clin Endocrinol Metab. 1996;81(2):577–579. doi: 10.1210/jcem.81.2.8636270.
   PubMed Web of Science ®Google Scholar
• Bennedbaek FN, Hegedüs L. The value of ultrasonography in the diagnosis and follow-up of subacute thyroiditis. Thyroid. 1997;7(1):45–50. doi: 10.1089/thy.1997.7.45.
   PubMed Web of Science ®Google Scholar
• Topuzovic N, Smoje J, Karner I. The therapeutic approach in subacute (de Quervain’s) thyroiditis. J Nucl Med. 1997;38(10):1665.
   PubMed Web of Science ®Google Scholar
• Mizukoshi T, Noguchi S, Murakami T, et al. Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone. Intern Med. 2001;40(4):292–295. doi: 10.2169/internalmedicine.40.292.
   PubMed Web of Science ®Google Scholar
• Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994;96(2):115–123. doi: 10.1016/0002-9343(94)90131-7.
   PubMed Web of Science ®Google Scholar
• McDougall R, Sibley J, Haga M, et al. Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol. 1994;21:1207–1213.
   PubMed Web of Science ®Google Scholar
• Curtis JR, Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006;55(3):420–426. doi: 10.1002/art.21984.
   PubMed Web of Science ®Google Scholar
• Waljee AK, Rogers MA, Lin P, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415. doi: 10.1136/bmj.j1415.
   PubMed Web of Science ®Google Scholar
• Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009;68(7):1119–1124. doi: 10.1136/ard.2008.092163.
   PubMed Web of Science ®Google Scholar
• Kubota S, Nishihara E, Kudo T, et al. Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan. Thyroid. 2013;23(3):269–272. doi: 10.1089/thy.2012.0459.
   PubMed Web of Science ®Google Scholar
• Hepsen S, Akhanli P, Sencar ME, et al. The evaluation of low- and high-dose steroid treatments in subacute thyroiditis: a retrospective observational study. Endocr Pract. 2021;27(6):594–600. doi: 10.1016/j.eprac.2020.11.009.
   PubMed Web of Science ®Google Scholar
• Sato J, Uchida T, Komiya K, et al. Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis. Endocrine. 2017;55(1):209–214. doi: 10.1007/s12020-016-1122-3.
   PubMed Web of Science ®Google Scholar
• Xu S, Jiang Y, Jia A, et al. Comparison of the therapeutic effects of 15 mg and 30 mg initial dosage of prednisolone daily in patients with subacute thyroiditis: protocol for a multicenter, randomized, open, parallel control study. Trials. 2020;21(1):418. doi: 10.1186/s13063-020-04337-8.
   PubMed Web of Science ®Google Scholar
• Rioux C, Little TD. Missing data treatments in intervention studies: What was, what is, and what should be. Int J Behav Dev. 2021;45(1):51–58. doi: 10.1177/0165025419880609.
   Web of Science ®Google Scholar
• Nishihara E, Ohye H, Amino N, et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008;47(8):725–729. doi: 10.2169/internalmedicine.47.0740.
   PubMed Web of Science ®Google Scholar
• Schenke S, Klett R, Braun S, et al. Thyroiditis de Quervain. Are there predictive factors for long-term hormone-replacement? Nuklearmedizin. 2013;52(4):137–140. doi: 10.3413/Nukmed-0536-12-10.
   PubMedGoogle Scholar
• Benbassat CA, Olchovsky D, Tsvetov G, et al. Subacute thyroiditis: clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005. J Endocrinol Invest. 2007;30(8):631–635. doi: 10.1007/bf03347442.
   PubMed Web of Science ®Google Scholar
• Li F, Wu Y, Chen L, et al. Initial treatment combined with Prunella vulgaris reduced prednisolone consumption for patients with subacute thyroiditis. Ann Transl Med. 2019;7(3):45–45. doi: 10.21037/atm.2019.01.07.
   PubMed Web of Science ®Google Scholar
• Volpé R. The management of subacute (DeQuervain’s) thyroiditis. Thyroid. 1993;3(3):253–255. doi: 10.1089/thy.1993.3.253.
   PubMed Web of Science ®Google Scholar
• Arao T, Okada Y, Torimoto K, et al. Prednisolone dosing regimen for treatment of subacute thyroiditis. J Uoeh. 2015;37(2):103–110. doi: 10.7888/juoeh.37.103.
   PubMedGoogle Scholar